4Stein DJ, Maud CM, BouwerC. Use of the selective aerotonin reuptake inhibitor eitalopram in obsessive compulsive disorder. J Scrotonin Res,1996,1:29 -33.
5Koponen H, Lepela U, Leinonen E,et al. Citalopram in the treatment of obsessive compulsive disorder: an open pilot study. Acta Psychiatr Scand, 1997,96 (3) :343 - 346.
6Tenike NA. Approaches to the patient with treat-refractory obsessivecompulsive disorder. J Clin Psychiatry, 1990,51 (2) : 15.
7Milne RJ,Goak I. Citslopram:a review of its pharmaeodynamic and pharmacokinetic properties,and therapeutic potential in depressive illness. Drugs J991,41 (4) :450.
8Fuller RW. Serotonin uptake inhibitors:uses in therapy and in laboratory research. Prog Drug Res,1995,45(1 ) :167.
3[3]Edwarde JG, Alexander JR, Gordon A, et al. Controlled trial of sulpiride in chronic schizophrenic patients. Br J Psychiatry, 1980,137 :522～529
4[4]Alfredsson G,Bierkenstedt L, Edman G,et al. Relationship between drug concentrations in serum and CSF,clinical effects and monoaminergic variadles in schizophrenic patients treated with sulpiride or chlorpromazine. Acta Scand Psychiatrica,1984,69(suppl 311):49～74
5[5]Allfredsson G, Harnryd C,Wiesel FA. Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients-relationship to drug concentrations. Psychopharmacology, 1985,85 : 8 ～ 13
